Breaking News, Collaborations & Alliances

Dr. Reddy’s, Amgen Enter Strategic Marketing Pact

Dr. Reddy’s to provide regulatory and commercial services for three Amgen products

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Reddy’s Labs Ltd. has entered into a strategic collaboration with Amgen to market and distribute three Amgen products in India in the areas of oncology and cardiology. Dr. Reddy’s will provide regulatory and commercial services to seek approval and launch Kyprolis (carfilzomib), BLINCYTO (blinatumomab) and Repatha (evolocumab) in India.   Alok Sonig, Dr. Reddy’s executive vice president and head of India Business & Global Business Development said, “We are excited about our strategic ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters